The biotechnology industry’s growth prospects appear promising due to increasing demand for innovative healthcare solutions, growing global healthcare needs, government initiatives, adoption of advanced technologies, and scientific breakthroughs. Biotech companies are constantly pushing boundaries to develop new treatments and therapies.
Given the industry’s bright prospects, investors could consider buying fundamentally strong biotech stocks Harmony Biosciences Holdings, Inc. (HRMY), Illumina, Inc. (ILMN), and Halozyme Therapeutics, Inc. (HALO).
